Home » Stocks » GMED

Globus Medical, Inc. (GMED)

Stock Price: $62.68 USD 0.18 (0.29%)
Updated Mar 1, 2021 4:00 PM EST - Market closed
Market Cap 6.25B
Revenue (ttm) 789.04M
Net Income (ttm) 102.29M
Shares Out 98.58M
EPS (ttm) 1.01
PE Ratio 62.06
Forward PE 34.13
Dividend n/a
Dividend Yield n/a
Trading Day March 1
Last Price $62.68
Previous Close $62.50
Change ($) 0.18
Change (%) 0.29%
Day's Open 63.26
Day's Range 62.44 - 63.95
Day's Volume 571,066
52-Week Range 33.41 - 68.24

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 1 week ago

Globus Medical's (GMED) spinal implant business performance varies by region in Q4.

Zacks Investment Research - 1 week ago

Globus Medical (GMED) delivered earnings and revenue surprises of 13.73% and -0.34%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 1 week ago

Shares of Globus Medical (NYSE:GMED) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 18.37% over the past year to $0.58, which ...

GlobeNewsWire - 1 week ago

AUDUBON, Pa., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and...

Zacks Investment Research - 2 weeks ago

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 1 month ago

AUDUBON, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and fu...

Zacks Investment Research - 1 month ago

Globus Medical's (GMED) recent product launches are seeing tremendous uptake.

Zacks Investment Research - 2 months ago

Globus Medical (GMED) saw a visible rebound in its revenue trend in the third quarter.

Seeking Alpha - 2 months ago

Globus Medical: Entry At The Pullback Paid Off, Upside On Entry Today Equally Exciting

GlobeNewsWire - 2 months ago

AUDUBON, Pa., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, was recently awarded a group purchasing agreement with Premier, o...

Zacks Investment Research - 2 months ago

Investors continue to be optimistic about Globus Medical (GMED) on robust product uptake and prominent sales trend improvement in the third quarter.

Zacks Investment Research - 3 months ago

Globus Medical (GMED) is optimistic about maintaining robust product portfolio along with strength in its domestic spine business.

Zacks Investment Research - 3 months ago

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

GlobeNewsWire - 3 months ago

New ExcelsiusGPS® Interbody Solutions module expands system for planning and navigating the entire interbody fusion procedure New ExcelsiusGPS® Interbody Solutions module expands system for pl...

Zacks Investment Research - 4 months ago

Globus Medical's (GMED) spinal implant business performance varies by region in Q3.

Seeking Alpha - 4 months ago

Globus Medical, Inc. (GMED) CEO Dave Demski on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 4 months ago

Globus Medical (GMED) delivered earnings and revenue surprises of 58.06% and 9.30%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 4 months ago

AUDUBON, Pa., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended Sept...

Zacks Investment Research - 4 months ago

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 4 months ago

AUDUBON, Pa., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended S...

Seeking Alpha - 4 months ago

Globus Medical Has Reached The 10% Pullback We Were Hoping For - Time For Entry

Zacks Investment Research - 4 months ago

Investors continue to be optimistic about Globus Medical (GMED) on robust product uptake and prominent sales trend improvement since the second quarter.

GlobeNewsWire - 4 months ago

AUDUBON, Pa., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will participate as a platinum sponsor at the ...

Zacks Investment Research - 5 months ago

Robotics stocks offer great opportunities for growth investors and recent adoptions have accelerated the industry's growth rapidly.

Other stocks mentioned: ABB, BRKS, TER
Investors Business Daily - 5 months ago

A Relative Strength Rating upgrade for Globus Medical shows improving technical performance. Will it continue?

Zacks Investment Research - 5 months ago

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 5 months ago

Globus Medical is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Zacks Investment Research - 6 months ago

Globus Medical (GMED) witnesses a significant rebound from mid-April through the remainder of Q2.

Seeking Alpha - 6 months ago

Globus Medical Climbs 18.12% From Q2 Exit - Beats EPS By $0.18; But Let's Not Jump In Just Yet

Zacks Investment Research - 6 months ago

Globus Medical (GMED) witnesses dismal segmental and international performance in the second quarter owing to pandemic-led adversities.

The Motley Fool - 6 months ago

The medical device maker reported second-quarter results that were much better than expected.

Seeking Alpha - 6 months ago

Globus Medical, Inc. (GMED) CEO Dave Demski on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 6 months ago

Globus Medical (GMED) delivered earnings and revenue surprises of 163.64% and 49.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 6 months ago

AUDUBON, Pa., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter e...

Zacks Investment Research - 7 months ago

Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

24/7 Wall Street - 7 months ago

Health care is supposed to be a very defensive sector in investing. After all, diseases and conditions such as cancer, diabetes, heart disease, kidney failure, dementia, joint damage and spina...

Other stocks mentioned: ABT, BAX, BSX, EW, JNJ, MDT, NUVA, SYK
GlobeNewsWire - 7 months ago

AUDUBON, Pa., July 21, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended...

The Motley Fool - 8 months ago

Big data is becoming a big factor in the healthcare industry.

Other stocks mentioned: CERN, HCAT
InvestorPlace - 8 months ago

Robotics stocks offer multi-decade growth potential. These 10 stocks offer some of the best exposure to this attractive trend.

Other stocks mentioned: ABB, AVAV, BOTZ, FLIR, IRBT, ISRG, STXS, TRMB
Zacks Investment Research - 8 months ago

Globus Medical (GMED) notes that the U.S. spine business bottomed in the first full week of April, witnessing a decline of about 70% from its pre-COVID 19 pace.

Seeking Alpha - 9 months ago

Globus Medical, Inc. (GMED) CEO Dave Demski on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 9 months ago

Globus Medical (GMED) witnesses around $20 million of COVID-19 related adverse impact on its Q1 sales.

The Motley Fool - 9 months ago

The medical-device maker's revenue and earnings fell below Wall Street expectations.

Zacks Investment Research - 9 months ago

Globus Medical (GMED) delivered earnings and revenue surprises of -27.50% and -4.65%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 10 months ago

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

InvestorPlace - 11 months ago

Healthcare stocks are in the spotlight as the coronavirus brings to light the importance of collecting data and using it to predict outcomes.

Other stocks mentioned: HCAT, TDOC
Zacks Investment Research - 11 months ago

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

Benzinga - 11 months ago

Globus Medical Inc’s (NYSE: GMED) shares have declined around 33% from their year-end 2019 high, and the company has a strong balance sheet that can be used to acquire assets at depressed valu...

GlobeNewsWire - 11 months ago

AUDUBON, Pa., March 11, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the Board of Directors authorized the repurcha...

Zacks Investment Research - 1 year ago

Globus Medical (GMED) registers impressive growth within U.S. Spine on record recruiting of competitive representatives in Q4.

About GMED

Globus Medical, a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pa... [Read more...]

Industry
Medical Devices
IPO Date
Aug 3, 2012
CEO
David Demski
Employees
2,200
Stock Exchange
NYSE
Ticker Symbol
GMED
Full Company Profile

Financial Performance

In 2020, Globus Medical's revenue was $789.04 million, an increase of 0.47% compared to the previous year's $785.37 million. Earnings were $102.29 million, a decrease of -34.10%.

Financial Statements

Analyst Forecasts

According to 16 analysts, the average rating for Globus Medical stock is "Buy." The 12-month stock price forecast is 71.47, which is an increase of 14.02% from the latest price.

Price Target
$71.47
(14.02% upside)
Analyst Consensus: Buy